CD40 Ligand-Induced Apoptosis is Fas-Independent in Human Multiple Myeloma Cells

References

• Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J. P., Van Kooten C., Liu Y. J., Rousset E, Saeland S. The CD40 antigen and its ligand. Ann. Rev. Immunol 1994; 12: 881–992
   PubMed Web of Science ®Google Scholar
• Van Kooten C., Banchereau J. Function of CD40 on B cells, dendritic cells and other cells. Curr. Opin Immunol. 1997; 9: 330–337
   PubMed Web of Science ®Google Scholar
• Grammer A. C., Bergman M. C., Miura Y., Fujita K., Davis L. S., Lipsky P. E. The CD40 ligand expressed by human B cells co-stimulates B cell responses. J. Immunol. 1995; 154: 4996–5010
   PubMed Web of Science ®Google Scholar
• Gordon J., Katira A., Holder M., MacDonald I., Pound J. Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens. Cell. Mai. Biol. 1994; 40(suppll)1–13
   PubMedGoogle Scholar
• Hollenbaugh D., Ochs H. D., Noelle R. J., Ledbetter J. A., Aruffo A. The role of CD40 and its ligand in the regulation ofthe immune response. Immunol. Rev. 1994; 138: 23–37
   PubMed Web of Science ®Google Scholar
• Splawski J. B., Fu S. M., Lipsky P. E. Immunoregula-tory role of CD40 in human B cell differentiation. J. Immunol. 1993; 150: 1276–1285
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Joshua D. E., Williams G. T., Smith C. A., Gordon J., MacLennan I. C. M. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y. J. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720–722
   PubMed Web of Science ®Google Scholar
• Koopman G., Keehnen R. M. J., Lindhout E., Zhou D. F. H., de Groot C., Pals S. T. Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to folli-cular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur. J. Immunol. 1997; 17: 1–7
   Web of Science ®Google Scholar
• Miyashita T., McLlrath M. J., Grammer A. C., Miura Y., Attrep J. F., Shimaoka Y, Lipsky P. E. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. J. Immunol. 1997; 158: 4620–4633
   PubMed Web of Science ®Google Scholar
• Merville P., Dechanet J., Desmouliere A., Durand I., de Bouteiller O., Garrone P., Banchereau J., Liu Y. J. Bcl-2 tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 1996; 183: 227–236
   PubMed Web of Science ®Google Scholar
• Tong A. W., Zhang B. Q., Mues G., Solano M., Hanson T., Stone M. J. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood 1994; 84: 3026–3033
   PubMed Web of Science ®Google Scholar
• Westendorf J. J., Ahmann G. A., Armitage R. J., Spriggs M. K., Lust J. A., Greipp PR., Katzmann J. A., Jelinek D. F. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 1994; 152: 117–128
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Bataille R., Robilard N., Harous-seau J. L., Rapp M. J., Juge-Morineau N., Wijdenes J., Amlot M. Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 1994; 84: 2597–2603
   PubMed Web of Science ®Google Scholar
• Tong A. W., Stone M. J. CD40 and the effect of anti-CD40 binding on human multiple myeloma clonogenicity. Leukemia Lymphoma 1996; 21: 1–8
   PubMed Web of Science ®Google Scholar
• Tong A. W., Banchereau J., Chen J., Ordonez G., Stone M. J. 1999, Activation of apoptotic elements by CD40 ligand in human multiple myeloma cells (manuscript in preparation)
   Google Scholar
• Bergamo A., Bataille R., Pellat-Deceunyck C. CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2. Br. J. Haematol. 1997; 97: 652–655
   PubMed Web of Science ®Google Scholar
• Ledbetter J. A., Grosmaire L. S., Hollenbaugh D., Aruffo A., Nadler S. G. Agonistic and antagonistic properties of CD40 MAb G28–5 are dependent on binding valency. Circul. Shock 1994; 44: 67–72
   PubMedGoogle Scholar
• Curnock A. P., Knox K. A. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth and apoptosis in CD40-triggered Ramos-Burkitt lym-phoma B cells. Cell. Immunol. 1998; 187: 77–87
   PubMed Web of Science ®Google Scholar
• Xerri L., Bouabdallah R., Devilard E., Hassoun J., Stoppa A. M., Birg F. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation. Br. J. Cancer 1998; 78: 225–232
   PubMed Web of Science ®Google Scholar
• Hollenbaugh D., Ochs H. D., Noelle R. J., Ledbetter J. A., Aruffo A. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 1994; 138: 23–37
   PubMed Web of Science ®Google Scholar
• Lederman S., Yellin M., Cleary A., Pernis A., Inghirami G., Cohn L., Covey L., Lee J., Rothman P., Chess L. the T-BAM/CD40 L molecule on helper T lymphocytes augments lymphokine-induced B cell immunoglobulin isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 1994; 152: 163–185
   PubMedGoogle Scholar
• Tong A. W., Lee S. C., Stone M. J. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells. Blood 1987; 69: 238–245
   PubMed Web of Science ®Google Scholar
• Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M. Exposure of phosphati-dyl-serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophases. J. Immunol. 1992; 148: 2207–2216
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single step method of isolation by acid guanidium thioglycanate-phenol-chloro-form extraction. Annal Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., Strober W. Immunoblotting. In Current Protocols in Immunology, 1st ed. Greene and Wiley, New York 1991; 8.10.1–8.10.4
   Google Scholar
• Bajorah J., Chalupny N. J., Marken J. S., Siadak A. W., Sko-nier J., Gordon M., Hollenbaugh D., Noelle R. J., Ochs H. D., Aruffo A. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Biochemistry 1995; 34: 1833–1844
   PubMed Web of Science ®Google Scholar
• Papayoti M. H., Tong A. W., Banchereau J., Stone M. J. Induction of human breast carcinoma cell apoptosis by CD40-ligand. Proc. A.A.C.R. 1998; 39: 582, (abstract)
   Google Scholar
• Dirks W., Schone S., Uphoff C., Quentmeier H., Pradella S., Drexler H. G. Expression and fucntion of CD95 (Fas/Apo-1) in leukaemia-lymphoma tumour lines. British J. Hematol. 1997; 96: 584–593
   PubMed Web of Science ®Google Scholar
• Egle A., Villunger A., Marschitz I., Kos M., Hittmair A., Lukas P., Grunewald K., Greil R. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status. British J. Haematol. 1997; 97: 418–428
   PubMed Web of Science ®Google Scholar
• Landowski T. H., Qu N., Buyuksal I., Painter J. S., Dalton W. S. Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997; 90: 4266–4270
   PubMed Web of Science ®Google Scholar
• Komada Y., Inaba H., Zhou Y. W., Zhang X. L., Tanaka S., Azuma E., Sakurai M. mRNA expression of Fas receptor (CD95(-associated proteins (Fas-associated phos-phatase-l/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines. British J. Haematol. 1997; 99: 325–330
   PubMed Web of Science ®Google Scholar
• Beg A. A., Baltimore D. An essential role for NF-kappaB in preventing TNFalpha-induced cell death. Science 1996; 274: 782–784
   PubMed Web of Science ®Google Scholar
• Carbone A., Glogini A., Gattei V., Aldinucci D., Degan M., De Paoli P., Zagonel V., Pinto A. Expression of Functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780–789
   PubMed Web of Science ®Google Scholar
• Hostager B. S., Hsing Y, Harms D. E., Bishop G. A. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 1996; 157: 1047–1053
   PubMed Web of Science ®Google Scholar
• Legresle C., Bella C., Daniel P. T., Krammer P. H., Defrance T. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule. J. Immunol. 1995; 154: 5746–5756
   PubMed Web of Science ®Google Scholar
• Law C. L., Wormann B., LeBien T. W. Analysis of expression and function on normal and leukemic human B cell precursors. Leukemia 1990; 4: 732–738
   PubMed Web of Science ®Google Scholar
• Hsu Y. M., Lucci J., Su L., Ehrenfels B., Garber E., Thomas D. Heteromultimeric complexes of CD40 ligand are present on cell surface of human T lymphocytes. J. Biol. Chem. 1997; 272: 911–915
   PubMed Web of Science ®Google Scholar
• Snapper CM., Kehry MR., Castle B. E., Mond J. J. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. J. Immunol. 1995; 154: 1177–1187
   PubMed Web of Science ®Google Scholar
• Hess S., Engelmann H. J. Exp. Med. 1996; 40: 159–167, A novel function of CD: Induction of cell death in transformed cells., 183;
   Web of Science ®Google Scholar
• Rissoan M. C., Van Kooten C., Chomarat P., Galibert L., Durand I., Thivolet-Bejui E, Miossec P., Banchereau J. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin. Exp. Immunol. 1996; 106: 481–490
   PubMed Web of Science ®Google Scholar
• Peguet-Navarro J., Dalbiez-Gauthier C., Moulon C., Ber-thier O., Reano A., Gaucherland M., Banchereau J., Rous-set F., Schmitt D. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J. Immunol. 1997; 158: 144–152
   PubMed Web of Science ®Google Scholar
• Eliopoulos A. G., Stack M., Dawson C. W., Kaye K. M., Hodgkin L., Sihota S., Rowe M., Young L. S. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 1997; 14: 2899–916
   PubMed Web of Science ®Google Scholar
• Hsu H., Shu H. B., Pan M. G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299–308
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Amiot M., Robillard N., Wijdenes J., Bataille R. CD 1 la-CD 18 and CD 102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation. Cancer Res 1996; 56: 1909–1916
   PubMed Web of Science ®Google Scholar
• Urashima M., Chauhan D., Uchiyama H., Freeman G. J., Anderson K. C. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995; 85: 1903–1912
   PubMed Web of Science ®Google Scholar
• Funakoshi S., Longo D. L., Beckwith M., Conley D. K., Tsarfaty G., Tsarfaty I., Armitage R. J., Fanslow W. C., Spriggs M. K., Murphy W. J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994; 83: 2787–2794
   PubMed Web of Science ®Google Scholar
• Kaufman Y., Many A., Rechavi G., Mor O., Biniaminov M., Rosenthal E., Levanon M., Davidsohn J., Aizman I., Mark Z., Brok-Simoni F., Ramot B. Lymphoma with recurrent cycles of spontaneous remission and relapse -Possible role of apoptosis. New Engl. J. Med. 1995; 332: 507–511
   PubMed Web of Science ®Google Scholar
• Murphy W. J., Funakoshi S., Beckwith M., Rushing S. E., Conley D. K., Armitage R. J., Fanslow W. C., Rager H. C., Taub D. D., Ruscetti F. W., Longo D. L. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes. Blood 1995; 86: 1946–1953
   PubMed Web of Science ®Google Scholar
• Wang D., Freeman G. J., Levine H., Ritz J., Robertson M. J. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of the human B-cell malignancies. Br. J. Haemalol. 1997; 97: 409–417
   PubMed Web of Science ®Google Scholar
• Gruss H. J., Dower S. K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lym-phomas. Blood 1995; 85: 3378–3404
   PubMed Web of Science ®Google Scholar
• Hallek M., Bergsagel P. L., Anderson K. C. Multiple myeloma: increasing evidence for a multi-step transformation process. Blood 1998; 91: 3–21
   PubMed Web of Science ®Google Scholar
• Garrone P., Neidhardt E. M., Garcia E., Balibert L., van Kooten C., Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 1995; 182: 1265–1273
   PubMed Web of Science ®Google Scholar
• Schattner E. J., Elkon K. B., Yoo D. H., Tumang J., Krammer P. H., Crow M. K., Friedman S. M. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 1995; 182: 1557–1565
   PubMed Web of Science ®Google Scholar
• Cheng G., Cleary A. M., Ye Z. S., Hong D. I., Lederman S., Baltimore D. Involvement of CRAFI, a relative of TRAF, in CD40 signaling. Science 1995; 267: 1494–1498
   PubMed Web of Science ®Google Scholar
• Craxton A., Shu G., Graves J., Saklatvala J., Krebs E. G., Clark E. A. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 1998; 161: 3225–3236
   PubMed Web of Science ®Google Scholar
• Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T, Suzuki K., Aizawa S., Watanabe T, Mosailos G., Kieff E., Yamamoto T., Inoue J. Identification or'TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from the amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 1996; 271: 28745–28748
   PubMed Web of Science ®Google Scholar
• Ishida T., Tojo T, Aoki T, Kobayashi N., Ohishi T., Watanabe T., Yamamoto T, Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 9437–9442
   PubMed Web of Science ®Google Scholar
• Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C. F., Yagita H., Okumura K. TRAF5. an activator of NF-kB and putative signal transducer for the lym-photoxin-B receptor. J. Biol. Chem. 1996; 271: 14661–14664
   PubMed Web of Science ®Google Scholar
• Rothe M., Sarma V, Dixit V. M., Goeddel D. C. TRAF2-mediated activation of NF-kB by TNF receptor 2 and CD40. Science 1995; 269: 1424–1427
   PubMed Web of Science ®Google Scholar
• Baldwin A. S., Jr. The NF-κB and IκB proteins: New discoveries and insights. Ann Rev. Immunol. 1996; 14: 649–683
   PubMed Web of Science ®Google Scholar
• Ludewig B., Henn V., Schroder J. M., Graf D., Kroczek R. A. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+CD45RA+ T cells with dendritic cells. Eur. J. lmmunol. 1996; 26: 3137–3143
   PubMed Web of Science ®Google Scholar
• Berenson J. R., Bergsagel P. L., Munshin N. Initiation and maintenance of multiple myeloma. Semin. Hematol. 1999; 36(1 suppl 3)9–13
   PubMed Web of Science ®Google Scholar